alexa Optic Characteristics Of Anticancer Drug NSC 631570 In Urine Samples Sort Healthy Donors And Prostate Adenocarcinoma Patients: Can It Be Exploited For The Cancer Diagnostics?
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

14th World Cancer & Anti-Cancer Therapy Convention
November 21-23, 2016 Dubai, UAE

Larysa M Skivka, Olexander Fedorchuk, Mariia Rudyk and Wassil Nowicky
Taras Shevchenko National University, Ukraine
National Academy of Sciences of Ukraine, Ukraine
Ukranian Anticancer Institute, Austria
ScientificTracks Abstracts: J Cancer Sci Ther
DOI: 10.4172/1948-5956.C1.093
Abstract
NSC 631570 (the mixture of alkaloids from C. majus) has shown anticancer activities against different types of solid tumor. Previous studies showed an anticancer effect of NSC 631570 in prostate cancer patients. The cytotoxic effect of the drug was evident in preclinical studies in prostate cancer cell line (PC-3). The aim of the work was to perform comparative investigation of optic characteristics of urine samples from prostate cancer patients (PCs) and healthy volunteers (HVs) to confirm different uptake of alkaloids mixture in both normal and cancer patients. Five PCs and five HVs were recruited to participate in this study. Urine samples were obtained before and 2, 4 and 6 hours after the sublingual administration of the drug. The UV light absorption spectrum characteristic for NSC 631570 was registered 2 h after the drug administration in HVs. PC1 showed an absorption spectrum similar to NSC 631570 4 hours after the drug intake. But absorption spectra of PC 2-5 was completely different during the entire observation period when compared with those observed in HVs (p<0.05). Patterns of urine fluorescence in PCs had substantial differences from those in HVs. Urine fluorescence was increasing in all PCs after the drug administration, till the end of the observation period followed by a moderate decrease of the fluorescence intensity 6 hours after the drug intake. Thus urine optic characteristics after the drug intake make the differences between PCs and HCs. It suggests that this method could be potentially used to test whether nonclinically pathologic subject might be affected by cancer.
Biography

Larysa M Skivka has completed her PhD from R E Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine and Post-doctoral studies from Taras Shevchenko National University of Kyiv. She is currently the Head of the Department of Microbiology and General Immunology of SCE Institute of Biology - Taras Shevchenko National University of Kyiv. Her areas of scientific activities are: Immunomodulation as a component of adjuvant cancer therapy and functional polarization of phagocytes in the pathogenesis of inflammatory diseases. She has published more than 13 papers in reputed journals and more than 40 abstracts in scientific congresses.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords